News blog

Japan investigations allege misconduct in large-scale clinical studies

The credibility of Japan’s clinical research system has come under fire as investigations report manipulation of data and conflict of interest involving the pharmaceutical company Novartis. Six published papers have been retracted, but Novartis has denied any wrongdoing. The country’s health minister has now started its own investigation, which is due to release its findings at the end of September. 

BACK TO ARTICLE

Tell a Friend

Please ensure that your friend is content to receive an email from us with a link to the article. Select the following link to view our Privacy Policy.

BACK TO ARTICLE